Targeted drug treatments attack specific abnormalities within cancer cells.
As an example, several targeted therapy drugs focus on a protein that some breast cancer cells overproduce called human epidermal growth factor receptor 2 (HER2).
The protein helps breast cancer cells grow and survive. By targeting cells that make too much HER2, the drugs can damage cancer cells.